Mustard's operation for transposition of the great arteries. Review of 200 cases

[Therapy of cardiogenic shock : A success story of German cardiology].

Herz·2019

Modification of the Mustard operation for surgical treatment of complete transposition by creating a confluence of the caval veins.

Cardiology in the young·2010

A review of 507 off-pump coronary bypass patients: a single center experience.

Interactive cardiovascular and thoracic surgery·2007

Effect of different operative techniques for myocardial revascularisation on hemodynamics and myocardial perfusion in a porcine model.

The Thoracic and cardiovascular surgeon·2005

[Short distal origin vein graft in diabetic foot syndrome].

Zentralblatt fur Chirurgie·2003

[Limb salvage in diabetic foot syndrome with pedal bypass using the in-situ technique].

Zentralblatt fur Chirurgie·2003

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Metacognition in AI-Supported Second Language Learning: A Systematic Review of Constructs, Measures, and Evidence (2016-2026).

Journal of Intelligence·2026

Caste, gender, and everyday resistance: a cultural psychological reading of Bama's fiction.

Frontiers in psychology·2026

Decoding inequalities in the journalistic field: A theoretical approach to how symbolic violence shapes journalistic career trajectories.

Journalism (London, England)·2026

Internal focalization influences real-life empathy: a literary contribution to wellbeing.

Frontiers in psychology·2026

Narrative Medicine: Crossing Health Humanities Cultures in China, France, and Italy.

The Journal of medical humanities·2026

Endorsement of common memory beliefs in TikTok videos about repression, trauma, and memory.

Memory (Hove, England)·2026

Related Experiment Videos

Mustard's operation for transposition of the great arteries. Review of 200 cases

Related Concept Videos

[Therapy of cardiogenic shock : A success story of German cardiology].

Modification of the Mustard operation for surgical treatment of complete transposition by creating a confluence of the caval veins.

A review of 507 off-pump coronary bypass patients: a single center experience.

Effect of different operative techniques for myocardial revascularisation on hemodynamics and myocardial perfusion in a porcine model.

[Short distal origin vein graft in diabetic foot syndrome].

[Limb salvage in diabetic foot syndrome with pedal bypass using the in-situ technique].

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Metacognition in AI-Supported Second Language Learning: A Systematic Review of Constructs, Measures, and Evidence (2016-2026).

Caste, gender, and everyday resistance: a cultural psychological reading of Bama's fiction.

Decoding inequalities in the journalistic field: A theoretical approach to how symbolic violence shapes journalistic career trajectories.

Internal focalization influences real-life empathy: a literary contribution to wellbeing.

Narrative Medicine: Crossing Health Humanities Cultures in China, France, and Italy.

Endorsement of common memory beliefs in TikTok videos about repression, trauma, and memory.

Related Experiment Videos

Mustard's operation for transposition of the great arteries. Review of 200 cases

Related Concept Videos

Related Articles